Published in Prog Urol on February 01, 2004
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc Natl Acad Sci U S A (2007) 3.60
Collecting duct renal cell carcinoma: a matched analysis of 41 cases. Eur Urol (2007) 2.30
Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol (2007) 2.09
[Current place of chemotherapy in the treatment of hormone-refractory metastatic prostate cancer]. Prog Urol (2005) 2.01
Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol (2004) 1.63
IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine (Baltimore) (2012) 1.54
MafB deficiency causes defective respiratory rhythmogenesis and fatal central apnea at birth. Nat Neurosci (2003) 1.48
Adrenomedullin as a therapeutic target in angiogenesis. Expert Opin Ther Targets (2010) 1.45
Strain-controlled magnetic domain wall propagation in hybrid piezoelectric/ferromagnetic structures. Nat Commun (2013) 1.43
Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival. Eur Urol (2006) 1.36
High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology. BJU Int (2008) 1.34
Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis. Am J Kidney Dis (2004) 1.32
Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma. Eur Urol (2006) 1.27
Cold ischemia time in renal transplantation is reduced by a timesheet in a French transplant center. Transplantation (2007) 1.21
Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells (2008) 1.19
Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study. J Urol (2003) 1.12
Attempted isolation of Nanobacterium sp. microorganisms from upper urinary tract stones. J Clin Microbiol (2003) 1.11
Renal tubular dysgenesis, a not uncommon autosomal recessive disorder leading to oligohydramnios: Role of the Renin-Angiotensin system. J Am Soc Nephrol (2006) 1.06
Tubulointerstitial nephritis and Fanconi syndrome in primary biliary cirrhosis. Am J Kidney Dis (2005) 1.06
Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesis. Hum Mutat (2011) 1.06
In vivo pH in metabolic-defective Ras-transformed fibroblast tumors: key role of the monocarboxylate transporter, MCT4, for inducing an alkaline intracellular pH. Int J Cancer (2011) 1.05
Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy. Can Urol Assoc J (2008) 1.03
Massive inflammatory syndrome and lymphocytic immunodeficiency in KARAP/DAP12-transgenic mice. Eur J Immunol (2002) 1.02
Conditional survival predictions after nephrectomy for renal cell carcinoma. J Urol (2009) 1.02
Follow-up of renal oncocytoma diagnosed by percutaneous tumor biopsy. Urology (2005) 1.01
Effects of early postnatal hypernutrition on nephron number and long-term renal function and structure in rats. Am J Physiol Renal Physiol (2007) 0.98
Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration. Thromb Haemost (2003) 0.98
Unclassified renal cell carcinoma: an analysis of 85 cases. BJU Int (2007) 0.98
Microarray gene expression profiling and analysis of bladder cancer supports the sub-classification of T1 tumours into T1a and T1b stages. BJU Int (2013) 0.97
Pathologies Associated with Serum IgG4 Elevation. Int J Rheumatol (2012) 0.96
Prostate cancer in renal transplant recipients. Nephrol Dial Transplant (2008) 0.95
Neural cell adhesion molecule expression in renal cell carcinomas: relation to metastatic behavior. Hum Pathol (2003) 0.94
Renal biopsy practice in France: results of a nationwide study. Nephrol Dial Transplant (2010) 0.93
Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature. Eur Urol (2012) 0.92
De novo renal cell carcinoma of native kidney in renal transplant recipients. Cancer (2005) 0.92
Acute tubulointerstitial nephritis complicating Legionnaires' disease: a case report. J Med Case Rep (2012) 0.92
Myocardial infarction is a complication of factor H-associated atypical HUS. Nephrol Dial Transplant (2010) 0.91
Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model? J Urol (2009) 0.89
Does management of erectile dysfunction after radical prostatectomy meet patients' expectations? Results of a national survey (REPAIR) by the French Urological Association. J Sex Med (2008) 0.89
Evolution of Anelloviridae strains distribution in serial blood and biopsy samples from a renal transplant patient. J Med Virol (2011) 0.89
BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus. Autoimmunity (2009) 0.89
Seminal vesicle invasion: what is the best adjuvant treatment after radical prostatectomy? BJU Int (2011) 0.89
Early postnatal overfeeding induces early chronic renal dysfunction in adult male rats. Am J Physiol Renal Physiol (2009) 0.87
Diagnosis and treatment of prostate cancers in renal-transplant recipients. Transplantation (2003) 0.86
[Percutaneous nephrolithotomy (PCNL) in subjects over the age of 70: a multicentre retrospective study of 210 cases]. Prog Urol (2004) 0.85
Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma. Int J Cancer (2009) 0.85
Prognostic variables to predict cancer-related death in incidental renal tumours. BJU Int (2008) 0.84
[Urinary stones in subjects over the age of sixty]. Prog Urol (2004) 0.84
Transurethral ureterorenolithotripsy using new automated irrigation/suction system controlling pressure and flow compared with standard irrigation: a randomized pilot study. J Endourol (2003) 0.84
A new family with hereditary lysozyme amyloidosis with gastritis and inflammatory bowel disease as prevailing symptoms. BMC Gastroenterol (2014) 0.84
Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma. BJU Int (2008) 0.83
Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion. J Neurosurg (2003) 0.83
Improved detection of urothelial carcinomas with fluorescence immunocytochemistry (uCyt+ assay) and urinary cytology: results of a French Prospective Multicenter Study. Lab Invest (2003) 0.82
Circulating microparticles in renal diseases. Nephrol Dial Transplant (2008) 0.82
Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone. Clin Experiment Ophthalmol (2010) 0.81
The spectrum of renal involvement in patients with inflammatory myopathies. Medicine (Baltimore) (2014) 0.81
Delayed diagnosis of fibrinogen Aα-chain amyloidosis after dual heart-kidney transplantation. Transpl Int (2012) 0.81
Membranoproliferative glomerulonephritis and mixed cryoglobulinemia after hepatitis C virus infection secondary to glomerular NS3 viral antigen deposits. Am J Nephrol (2012) 0.81
[Tamsulosin with or without Serenoa repens in benign prostatic hyperplasia: the OCOS trial]. Prog Urol (2002) 0.81
Remission of C3 glomerulopathy with rituximab as only immunosuppressive therapy. Clin Nephrol (2015) 0.80
Adrenomedullin blockade suppresses growth of human hormone-independent prostate tumor xenograft in mice. Clin Cancer Res (2013) 0.80
Laparoscopic living-donor nephrectomy: is it really better? Eur Urol (2010) 0.79
[Complications of "Acucise" balloon endopyelotomy]. Prog Urol (2003) 0.79
Complete pathological response after sequential therapy with sunitinib and radiotherapy for metastatic clear cell renal carcinoma. Anticancer Res (2012) 0.79
Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomy. World J Urol (2013) 0.79
[Renal cancer and second cancer: critical review of the literature]. Prog Urol (2007) 0.79
[Intravesical BCG instillations for the treatment of superficial bladder tumours in renal transplant recipients]. Prog Urol (2006) 0.78
[Urological problems encountered during pregnancy]. Prog Urol (2005) 0.78
[Management of positive margins after total prostatectomy for localized prostate cancer]. Prog Urol (2006) 0.78
Comparative safety and efficiency of five percutaneous kidney biopsy approaches of native kidneys: a multicenter study. Am J Nephrol (2012) 0.77
Association between anti-C1q antibodies and glomerular tuft necrosis in lupus nephritis. Clin Nephrol (2012) 0.77
[Prostate-sparing cystectomy: long-term functional and oncological results in a series of 25 cases]. Prog Urol (2004) 0.77
Hemolysis: a fatal complication of alkaptonuria in a severe renal failure patient. Clin Nephrol (2014) 0.76
Severe mesangiolysis in a patient exposed to glycol ether solvents. Nephrol Dial Transplant (2004) 0.76
Crescentic glomerulonephritis is part of hyperimmunoglobulinemia D syndrome. Pediatr Nephrol (2006) 0.76
Editorial comment on: Cytological punctures in diagnosis of renal tumours: a study on accuracy and reproducibility. Eur Urol (2008) 0.76
A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation. Transplantation (2012) 0.76
[Mycophenolate mofetil restores renal function and spares steroids during idiopathic nephrotic syndrome in children. A cohort study]. Nephrol Ther (2007) 0.75
Editorial comment on: Ultrasound-guided biopsy of homogenous solid renal masses. Eur Urol (2007) 0.75
Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis. Medicine (Baltimore) (2016) 0.75
[Prostate cancer at high risk of recurrence: results of 12 months of radiotherapy-hormone therapy]. Prog Urol (2005) 0.75